Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-25 3:41 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
120,000 | $0 | 195,000 (Direct) |
View |
| 2024-11-15 Option Award |
2024-11-18 1:36 pm |
N/A 2034-11-14 |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
225,000 | $0 | 225,000 (Direct) |
View |
Ownership |
2024-10-03 5:11 pm |
N/A N/A |
Vir Biotechnology Inc. | VIR | O'Byrne Jason EVP & Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2024-02-20 Option Award |
2024-02-22 5:28 pm |
N/A 2034-02-19 |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason Chief Financial Officer |
186,000 | $0 | 212,224 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 4:47 pm |
N/A 2033-02-20 |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason Chief Financial Officer |
131,000 | $0 | 131,000 (Direct) |
View |
| 2022-02-08 Exercise |
2022-02-08 7:27 pm |
N/A 2031-03-29 |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason Chief Financial Officer |
24,336 | $0 | 437,201 (Direct) |
View |
| 2022-02-08 Exercise |
2022-02-08 7:27 pm |
N/A N/A |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason Chief Financial Officer |
24,336 | $4.11 | 437,201 (Direct) |
View |
| 2021-12-20 Option Award |
2021-12-21 5:35 pm |
N/A 2031-12-19 |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason Chief Financial Officer |
147,000 | $0 | 147,000 (Direct) |
View |
Ownership |
2021-07-22 8:58 pm |
N/A 2031-03-29 |
Caribou Biosciences Inc. | CRBU | O'Byrne Jason See Remarks |
0 | $0 | 486,167 (Direct) |
View |